A pivotal Phase III trial of GMI-1271 in Patients With Acute Myeloid Leukemia.
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2017
At a glance
- Drugs GMI 1271 (Primary)
- Indications Acute myeloid leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors GlycoMimetics
- 15 Nov 2017 New trial record
- 08 Nov 2017 According to a GlycoMimetics media release, company plans to initiate this trial in mid of 2018.